Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags
Breaking news
Companies
Business
From
CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
April 04, 2024
Tags
Food and drink
Europe News
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
US: News
From
CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags
Science
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Pharmaceuticals
Health & Science
Amgen Inc
From
CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
Tags
Technology
NVIDIA Corp
Personal investing
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Companies
Health care industry
Business
From
CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
Tags
stocks
Market Outlook
Markets
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Madrigal Pharmaceuticals Inc
Viking Therapeutics Inc
Health & Science
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Weight management
Health & Science
Pharmaceuticals
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Companies
Health care industry
Business
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Health care industry
Drugs
Medicine
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Health & Science
Exchange/traded funds
Markets
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Companies
Breaking news
Health care industry
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
ASML Holding NV
U/S/ Markets
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Breaking News: Business
Novo Nordisk A/S
Business News
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Europe News
Markets
Pharmaceuticals
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Health care industry
Investment strategy
Breaking News: Investing
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Business News
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Markets
Stock Picks
stocks
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Economic events
Markets
Shell PLC
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Politics
Markets
Earnings
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Paramount Global
Warner Bros Discovery Inc
S&P Global Inc
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
World Markets
Paramount Global
Warner Bros Discovery Inc
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.